Comparison of mycophenolate versus methotrexate in combination with a calcineurin inhibitor for graft-versus-host disease prophylaxis in reduced-intensity allogeneic hematopoietic cell transplantation.
Study #: GV14-01b
Study Status: Published
Presentation(s)
2018, Tandem (Poster)
Inferior outcomes with cyclosporine and mycophenolate mofetil after myeloablative allogeneic hematopoietic cell transplantation.
Citation
Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn J-Y, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S.
Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2019, Sep 01: 25(9): 25(9):1744-1755. doi: 10.1016/j.bbmt.2019.05.019. Epub 2019, May 31. PMCID:PMC7039394.
PubMed
PMID: 31158502
Abstract